No Data
One company included, five companies deferred: Note regarding the going concern assumption, submitted in annual securities reports on the 23rd.
Among the annual securities reports and semiannual reports submitted on June 23, only one listed company included a note regarding the going concern assumption, citing the existence of events or conditions that cast significant doubt on the company’s ability to continue as a going concern. The company is as follows: ▽ Annual Securities Report <6740> JDI (fiscal year ending March 2026). Additionally, there were listed companies that, despite the presence of such events or conditions, determined that no material uncertainty related to the going concern assumption existed due to measures taken to resolve or mitigate these issues, and therefore omitted the related disclosure note.
Audit Consideration Item 26/03 – OTS: Whether there is a material uncertainty related to the going concern assumption.
Submitter: <4564> OncoTherapy Science, Inc. Date and Time of Submission: June 23, 2026, 15:47 Submitted Document: Annual Securities Report Fiscal Year: 25th Fiscal Period (from April 1, 2025 to March 31, 2026) <Principal Audit Matters Relating to Consolidated Financial Statements – Number of Items: 1> ▼ Assessment of the Reasonableness of Management’s Judgment Regarding the Existence of Material Uncertainty Related to Going Concern <First Two Sentences> The Company and its consolidated subsidiaries (hereinafter referred to as the “Company Group”
OncoTherapy Science: Confirmation Letter
OncoTherapy Science: Securities Report – Fiscal Year 2025 (April 1, 2025 – March 31, 2026)
Equity Change Report OTS (5.81% → 4.63%) Long Corridor A
Filer: Long Corridor Asset Management Limited Date and Time of Filing: June 15, 2026, 15:31 Submitted Document: Amendment Report (Cover Page = Amendment Report No. 18) Date Triggering Reporting Obligation: June 12, 2026 Reason for Filing Amendment Report: The holding ratio of shares or equivalent securities has decreased by more than 1%. Issuer: <4564> Oncocare Therapy Co., Ltd.
OTS Shareholding Change Report (5.81% → 5.81%) – Long Corridor A
Filer: Long Corridor Asset Management Limited Date and Time of Filing: June 11, 2026, 15:37 Document Filed: Amendment Report (Cover Page = Amendment Report No. 17) Date Triggering Reporting Obligation: June 9, 2026 Reason for Filing Amendment Report: Change of more than 1% in the breakdown of holdings of shares, etc. Issuer: <4564> ONCOtherapy Science, Inc.